fbpx
November 9, 2022

Reducing Inflammation May Lower Dementia Risk in RA Reducing Inflammation May Lower Dementia Risk in RA

The incidence of dementia in patients with rheumatoid arthritis who took either a biologic disease-modifying antirheumatic drug (bDMARD) or targeted synthetic DMARD (tsDMARD) was significantly lower […]
November 9, 2022

If a Saphenous Graft Is Available, Treat CLTI Surgically If a Saphenous Graft Is Available, Treat CLTI Surgically

CHICAGO – In patients with chronic limb-threatening ischemia (CLTI) and a usable saphenous vein segment, a surgical procedure leads to better outcomes than an endovascular approach, […]
November 9, 2022

Academic Dermatology: Gender Diversity Advances, Gaps Persist Academic Dermatology: Gender Diversity Advances, Gaps Persist

Women continue to be underrepresented among the leadership ranks of dermatology training programs, although the gender gap has closed in recent years, according to a recent […]
November 9, 2022

‘Skyrocketing’ Launch Prices for New Cancer Drug Need Reform ‘Skyrocketing’ Launch Prices for New Cancer Drug Need Reform

The cost of new cancer drugs continues to rise, with no end in sight, and there is currently no legislation to control this, concludes a new […]
November 9, 2022

Does Subclinical Hyperthyroidism Raise Fracture Risk? Does Subclinical Hyperthyroidism Raise Fracture Risk?

People with subclinical hyperthyroidism are at 34% greater risk of experiencing a fracture compared with those with normal thyroid function, new research shows. The finding, from […]
November 9, 2022

Don’t Wait for Patients to Bring Up Their GI Symptoms Don’t Wait for Patients to Bring Up Their GI Symptoms

Nearly three-quarters of Americans would wait before discussing GI symptoms with a health care provider if their bowel frequency or symptoms changed, with more than a […]
November 9, 2022

New Economic Study: Dapagliflozin Cost-Effective in Kidney Disease New Economic Study: Dapagliflozin Cost-Effective in Kidney Disease

The sodium-glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin (Farxiga) — despite the cost of the drug being high — is still a cost-effective option compared with standard of care […]
November 9, 2022

TNF Inhibitors Linked to Increased Multiple Sclerosis Risk TNF Inhibitors Linked to Increased Multiple Sclerosis Risk

Anti-tumor necrosis factor alpha (TNF-alpha) inhibitors are associated with an increased risk for multiple sclerosis (MS), especially among patients with rheumatic disease (RD), new research shows. […]
November 9, 2022

Higher Fibrosis Progression Rate in NAFLD Patients With Diabetes Higher Fibrosis Progression Rate in NAFLD Patients With Diabetes

Among people with nonalcoholic fatty liver disease (NAFLD), the fibrosis progression rate was higher among those who also had diabetes, according to new findings presented at the annual […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930931932933934935936937938939940941942943
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0